Authors

Nafila Al-Riyami

Publications 5

Research article Open access

Interference with Immunoassays of a Neonate on High Biotin: Case Report and Literature Review

Naeema Al Shibli, Azza Al Shidhani, Irfan Ullah et al. · Oman Medical Journal · 2024 · 10.5001/omj.2024.30

Biotin is sometimes administered in mega doses to children to treat certain inborn errors of metabolism. We report the case of a one-week-old newborn who was started on a ‘mitochondrial cocktail’ that contained a high dose of biotin. On day seven of life, his thyroid function test showed a biochemical picture of primar …

Research article Open access

Biochemical, Hematological, and Immunological Biomarkers as Predictors for Intensive Care Unit Admission in Patients with COVID-19

Zakariya Al Aamri, Fahad Zadjali, Nafila Al-Riyami et al. · Oman Medical Journal · 2022 · 10.5001/omj.2022.99

Objectives: To identify the biochemical, hematological, and immune biomarkers in COVID-19 patients on admission that are predictive of eventual admission to the intensive care unit (ICU). Methods: This retrospective cohort study was conducted on all confirmed COVID-19 cases hospitalized at Royal Hospital, Oman from 24 …

Research article Open access

Effect of Smokeless Tobacco Product, Afzal, on the Reproductive Hormones and Gonadal Pathology of Wistar Rats

Nawal M. Al-Mukhaini, Taher Baomar, Elsadig A. Eltayeb et al. · Sultan Qaboos University Journal for Science · 2020 · 10.24200/squjs.vol25iss1pp1-9

Afzal is a common smokeless tobacco product (STP) in Oman, and it is believed to contain toxins that may affect the reproductive hormones and hence reproductive function. This study assessed the effect of Afzal on the gonads of Wistar rats. In order to assess gonad toxicity induced by this STP, an aqueous extract of Af …

Research article Open access

Biclonal Gammopathy in Chronic Lymphocytic Leukemia: Case Report and Review of the Literature

Nafila Al-Riyami, Khalil Al-Farsi, Khalfan Al-Amrani et al. · Oman Medical Journal · 2015 · 10.5001/omj.2015.45

Monoclonal gammopathies are frequently seen in B-cell malignancies. Monoclonal proteins are seen in a significant proportion of patients with chronic lymphocytic leukemia (CLL), which is a clonal disorder of mature B cells. The use of more sensitive laboratory methods has enabled the detection of monoclonal proteins or …

Co-authors